Health news and discussion on TalkFuse.
Outrage as murderer is allowed Ozempic and plastic surgery – on the taxpayer’s dime – while ‘overeating’ on ‘lollies, chips and chocolate’
A prisoner named Alicia Schiller, who is serving a 16-year sentence for murder, has sparked public anger after reportedly being given access to the weight-loss drug Ozempic and plastic surgery at public expense. Critics have questioned why taxpayer funds are being used to provide such treatments to a convicted killer, particularly amid claims that she has been "overeating" on sweets, crisps and chocolate while in custody.
Details of exactly how the treatments were approved and their full cost have not been specified in the available report. The case has drawn criticism over prison healthcare spending and the appropriateness of cosmetic and weight-loss interventions being funded for inmates convicted of serious violent crimes.
In short
- Murderer Alicia Schiller reportedly given Ozempic and plastic surgery in prison.
- Treatments said to be funded by taxpayers, sparking outrage.
- Schiller is serving a 16-year sentence and allegedly overeats junk food.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Prisoners retain fundamental human rights, including access to necessary healthcare, regardless of their crimes. If Ozempic has been prescribed on genuine medical grounds—for instance, to address weight-related health conditions that could lead to serious complications in custody—denying it would constitute poor medical practice and potentially cruel treatment. Cosmetic procedures aside, medication for legitimate health conditions should be available to all in state care; setting a precedent of withholding healthcare based on perceived deservingness undermines the principle that all people deserve basic dignity and proper medical standards.
The case against
Taxpayers already bear substantial costs for the criminal justice system; funding elective or cosmetic treatments for serious offenders seems a misallocation of finite resources when many law-abiding citizens cannot access such interventions privately. The reported contradiction—receiving weight-loss medication whilst allegedly overeating on sweets and crisps—suggests the treatment is not being used responsibly or that the prisoner is not engaged in genuine health management. Public funds should prioritise essential, life-saving care within prisons; quality-of-life enhancements or treatments undermined by non-compliance represent poor stewardship of money ultimately drawn from ordinary taxpayers.
Explained simply
A prisoner serving a murder sentence has received a weight-loss drug and cosmetic surgery at taxpayer expense, sparking public criticism. Alicia Schiller, now 16 years into her sentence, had these treatments approved and funded through the state's prison healthcare system.
Critics have pointed to reports that Schiller has consumed large quantities of sweets and fatty foods whilst in custody, questioning whether public funding for weight-loss treatment was justified. The case has sparked wider debate about prison healthcare budgets and what types of medical and cosmetic care should be provided to inmates convicted of serious violent crimes.